Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion.

Moussalli MJ, Wu Y, Zuo X, Yang XL, Wistuba II, Raso MG, Morris JS, Bowser JL, Minna JD, Lotan R, Shureiqi I.

Cancer Prev Res (Phila). 2011 Dec;4(12):1961-72. doi: 10.1158/1940-6207.CAPR-10-0280. Epub 2011 Aug 31.

PMID:
21881028
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.

Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, Lynch P, Levin B, Fischer SM, Lippman SM.

Cancer Res. 2005 Dec 15;65(24):11486-92.

PMID:
16357157
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?

Il Lee S, Zuo X, Shureiqi I.

Cancer Metastasis Rev. 2011 Dec;30(3-4):481-91. doi: 10.1007/s10555-011-9321-0. Review.

PMID:
22037943
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis.

Mei YP, Liao JP, Shen J, Yu L, Liu BL, Liu L, Li RY, Ji L, Dorsey SG, Jiang ZR, Katz RL, Wang JY, Jiang F.

Oncogene. 2012 May 31;31(22):2794-804. doi: 10.1038/onc.2011.449. Epub 2011 Oct 10.

PMID:
21986946
[PubMed - indexed for MEDLINE]
5.

The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer.

Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris JS, Lippman SM.

FASEB J. 2007 Mar;21(3):743-53. Epub 2006 Dec 13.

PMID:
17167069
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.

Li X, Wan L, Geng J, Wu CL, Bai X.

J Thorac Oncol. 2012 Aug;7(8):1235-45. doi: 10.1097/JTO.0b013e318257cc6d.

PMID:
22617249
[PubMed - indexed for MEDLINE]
7.

Chromatin modification requirements for 15-lipoxygenase-1 transcriptional reactivation in colon cancer cells.

Zuo X, Morris JS, Shureiqi I.

J Biol Chem. 2008 Nov 14;283(46):31341-7. doi: 10.1074/jbc.M803729200. Epub 2008 Sep 17.

PMID:
18799463
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.

Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM.

Neoplasia. 2003 Mar-Apr;5(2):121-7.

PMID:
12659684
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Effects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in mice.

Zuo X, Peng Z, Wu Y, Moussalli MJ, Yang XL, Wang Y, Parker-Thornburg J, Morris JS, Broaddus RR, Fischer SM, Shureiqi I.

J Natl Cancer Inst. 2012 May 2;104(9):709-16. doi: 10.1093/jnci/djs187. Epub 2012 Apr 2.

PMID:
22472308
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.

Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA, Greenson JK, Normolle D, Hasan AA, Lawrence TS, Brenner DE.

Carcinogenesis. 1999 Oct;20(10):1985-95.

PMID:
10506115
[PubMed - indexed for MEDLINE]
Free Article
11.

White tea extract induces apoptosis in non-small cell lung cancer cells: the role of peroxisome proliferator-activated receptor-{gamma} and 15-lipoxygenases.

Mao JT, Nie WX, Tsu IH, Jin YS, Rao JY, Lu QY, Zhang ZF, Go VL, Serio KJ.

Cancer Prev Res (Phila). 2010 Sep;3(9):1132-40. doi: 10.1158/1940-6207.CAPR-09-0264. Epub 2010 Jul 28.

PMID:
20668019
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.

Hong SH, Avis I, Vos MD, Martínez A, Treston AM, Mulshine JL.

Cancer Res. 1999 May 1;59(9):2223-8.

PMID:
10232612
[PubMed - indexed for MEDLINE]
Free Article
13.

Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.

Wu Y, Fang B, Yang XQ, Wang L, Chen D, Krasnykh V, Carter BZ, Morris JS, Shureiqi I.

Mol Ther. 2008 May;16(5):886-92. doi: 10.1038/mt.2008.44. Epub 2008 Mar 18.

PMID:
18388920
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.

Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG.

Neoplasia. 2005 Mar;7(3):280-93.

PMID:
15799828
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells.

Wesley UV, Tiwari S, Houghton AN.

Int J Cancer. 2004 May 10;109(6):855-66.

PMID:
15027119
[PubMed - indexed for MEDLINE]
16.

15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation.

Gonzalez AL, Roberts RL, Massion PP, Olson SJ, Shyr Y, Shappell SB.

Hum Pathol. 2004 Jul;35(7):840-9.

PMID:
15257547
[PubMed - indexed for MEDLINE]
17.

Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.

Heslin MJ, Hawkins A, Boedefeld W, Arnoletti JP, Frolov A, Soong R, Urist MM, Bland KI.

Ann Surg. 2005 Jun;241(6):941-6; discussion 946-7.

PMID:
15912043
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Expression of 15-lipoxygenase-1 in human colorectal cancer.

Ikawa H, Kamitani H, Calvo BF, Foley JF, Eling TE.

Cancer Res. 1999 Jan 15;59(2):360-6.

PMID:
9927047
[PubMed - indexed for MEDLINE]
Free Article
19.

15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity.

Zhu H, Glasgow W, George MD, Chrysovergis K, Olden K, Roberts JD, Eling T.

Int J Cancer. 2008 Dec 15;123(12):2741-9. doi: 10.1002/ijc.23855.

PMID:
18785202
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.

Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T.

J Thorac Oncol. 2011 Jul;6(7):1152-61. doi: 10.1097/JTO.0b013e318216ee52.

PMID:
21597390
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk